Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on May 29, 2025
The Vision Council Foundation Announces Industry Partners and NYC Event for National Sunglasses Day 2025
GlobeNewswire
·
May 29, 2025
Alexandria, Virginia, May 29, 2025 (GLOBE NEWSWIRE) -- The Vision Council Foundation is proud to kick off the countdown to National Sunglasses Day 2025 with the announcement of an exciting event in New York City and a growing roster of industry sponsors. …
Silexion Therapeutics Announces Groundbreaking Preclinical Results: SIL204 Shows Strong Efficacy in Pancreatic, Colorectal, and Lung Cancers
GlobeNewswire
·
May 29, 2025
GRAND CAYMAN, Cayman Islands, May 29, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today …
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors
GlobeNewswire
·
May 29, 2025
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the addition of healthcare veteran Elizabeth Bierbower to its Board of Directors. "As we continue to …
Penn Highlands State College Partners with SAFE-T System to Provide Support for Victims of Sexual Assault
GlobeNewswire
·
May 29, 2025
DuBois, Pennsylvania, May 29, 2025 (GLOBE NEWSWIRE) -- Penn Highlands State College is partnering with Sexual Assault Forensic Examination-Telehealth (SAFE-T) System to enhance sexual assault care in the Centre County region. “We are excited to partner …
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
GlobeNewswire
·
May 29, 2025
Southlake, TX, May 29, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”)-powered medical technology company focused on transforming ECGs/EKGs to enable earlier detection …
Parexel Showcases Oncology Expertise at ASCO 2025; Company Selected to Present Five Posters at World’s Largest Oncology Event
GlobeNewswire
·
May 29, 2025
Parexel also launching a comprehensive Radiopharmaceuticals report at the meeting Onsite Parexel experts include recently appointed Chief Medical Officer and veteran oncologist Dr. Charlotte Moser, licensed medical oncologist and Global Therapeutic Area …
Lantern’s Cancer Program Reaches 1 Million Member Milestone
GlobeNewswire
·
May 29, 2025
DALLAS, May 29, 2025 (GLOBE NEWSWIRE) -- Lantern, the leading Specialty Care Platform connecting approximately 6 million members with the best surgery, cancer and infusion care, recently announced the expansion of its cancer program to serve 1 million …
BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic
GlobeNewswire
·
May 29, 2025
IND submission planned for mid-2025 with Phase 1 SAD data anticipated by year end BGE-102 induced weight loss in preclinical obesity models, both as monotherapy and in combination with GLP-1 receptor agonists Internally discovered compound has a novel …
Cannabix Technologies Enters Contract Manufacturing Agreement with Price Industries for BreathLogix Devices
GlobeNewswire
·
May 29, 2025
VANCOUVER, British Columbia, May 29, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report that it has selected …
Gain Therapeutics Announces Oral Presentation at 2nd GBA1 Meeting
GlobeNewswire
·
May 29, 2025
BETHESDA, Md., May 29, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …
Organic Living Soil LLC Joins Easy Environmental Solutions as Exclusive Dealer in Louisiana and Mississippi Following Initial Shipment
GlobeNewswire
·
May 29, 2025
WELCOME, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV), now doing business as Easy Environmental Solutions Inc., is proud to announce that Organic Living Soil, LLC has agreed to be the exclusive dealer/warehouser for …
Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals
GlobeNewswire
·
May 29, 2025
ROCKVILLE, Md., May 29, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals is expanding its partnership with TV personality and sports reporter Jay Glazer in a new content series featuring his wife, Rosie Glazer. The series, which launches its first episode …
Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs
GlobeNewswire
·
May 29, 2025
Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs Late-breaking data show infant respiratory syncytial virus (RSV) hospitalizations reduced by 69% in Spain following Beyfortus-only …
Communiqué de presse : L’avantage de Beyfortus pour la santé publique renforcé par la première comparaison en situation réelle des programmes de vaccination infantile et maternelle contre le VRS
GlobeNewswire
·
May 29, 2025
L’avantage de Beyfortus pour la santé publique renforcé par la première comparaison en situation réelle des programmes de vaccination infantile et maternelle contre le VRS Des données de dernière minute montrent que les hospitalisations dues au virus …
Drug Device Combination Products Market worth US$379.17 billion by 2030 with 9.3% CAGR | MarketsandMarkets™.
GlobeNewswire
·
May 29, 2025
Delray Beach, FL, May 29, 2025 (GLOBE NEWSWIRE) -- The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2025 to 2030, …
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, …
Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 29, 2025
ZUG, Switzerland and BOSTON, May 29, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior …
Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders
GlobeNewswire
·
May 29, 2025
Transaction is anticipated to be completed in third quarter 2025 Planned Cortigent Nasdaq listing intended to drive value for Vivani and Cortigent stockholders Cortigent is developing the Orion® Visual Cortical Prosthesis System to provide meaningful …
atai Life Sciences to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 29, 2025
NEW YORK and BERLIN, May 29, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, …